Comparing the PTEC-HT scaling program with usual care, a trial-based economic evaluation using patient-level data was conducted to examine the effectiveness and cost-effectiveness over time horizons ...
FDA official: 17 drugs approved using continuous manufacturing, growth seen in emerging tech program
FDA's Adam Fisher speaks at the 2026 REdI meeting. (Source: REdI) Adam Fisher, the staff director of the Office of Pharmaceutical Quality in the Center for Drug Evaluation and Research (CDER) at the ...
Abstract: The CRISPR-Cas9 gene editing, based on a bacterial immune mechanism, offers precise DNA editing techniques for gene therapy, disease treatment, and improved agricultural crops. This paper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results